Cleared Traditional

Blue Eye (TS-905)

K220434 · The Standard Co., Ltd. · Gastroenterology & Urology
Aug 2022
Decision
178d
Days
Class 2
Risk

About This 510(k) Submission

K220434 is an FDA 510(k) clearance for the Blue Eye (TS-905), a Submucosal Injection Agent (Class II — Special Controls, product code PLL), submitted by The Standard Co., Ltd. (Gunpo-Si, KR). The FDA issued a Cleared decision on August 12, 2022, 178 days after receiving the submission on February 15, 2022. This device falls under the Gastroenterology & Urology review panel. Regulated under 21 CFR 876.1500.

Submission Details

510(k) Number K220434 FDA.gov
FDA Decision Cleared SESE
Date Received February 15, 2022
Decision Date August 12, 2022
Days to Decision 178 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code PLL — Submucosal Injection Agent
Device Class Class II — Special Controls
CFR Regulation 21 CFR 876.1500
Definition Intended For Use In Gastrointestinal Endoscopic Procedures For Submucosal Lift Of Polyps, Adenomas, Early-stage Cancers Or Other Gastrointestinal Mucosal Lesions, Prior To Excision With A Snare Or Endoscopic Device.

Similar Devices — PLL Submucosal Injection Agent

All 8
Blue Eye
K241591 · The Standard Co., Ltd. · Jul 2024
LiftUp (Ref. Nr.: 200.56.01), LiftUp Kit (Ref. Nr.: 200.56.02)
K221385 · Ovesco Endoscopy AG · Aug 2022
Blue Beacon Submucosal Injectable Solution
K200071 · Micro-Tech (Nanjing) Co., Ltd. · Nov 2020
EverLift Submucosal Lifting Agent
K202376 · Gi Supply, Inc. · Sep 2020
EverLift Submucosal Lifting Agent
K191923 · Gi Supply · Jun 2020
EndoClot
K191254 · Endoclot Plus Co., Ltd. · Jan 2020